Thursday, 4 February 2021, 6:47 am
Greenlab (Green Relief NZ Ltd trading as Greenlab) based
at Lincoln University is positioning New Zealand at the
forefront of research-driven pharmaceutical-quality cannabis
cultivation and derivative products, is pleased to announce
that its subsidiary, Greenlab Australia Pty Ltd, has entered
into an agreement to supply pharmaceutical-grade,
cannabinoid pharmaceuticals to Cannvalate Pty Ltd, one of
Australia’s largest distributors.
Under the two-year
agreement, Greenlab will supply a range of certified
cannabis products that meet the high-quality standards set
by the Australian Therapeutic Goods Administration (TGA) and
meeting internationally recognized GMP requirements.
Greenlab and Cannvalate will non-exclusively distribute the
The Globe and Mail Bookmark Please log in to listen to this story. Also available in French and Mandarin. Log In Create Free Account
Getting audio file . This translation has been automatically generated and has not been verified for accuracy. Full Disclaimer
Sean Kilpatrick/The Canadian Press
More than 100 licensed cannabis companies and their subsidiaries have received tens of millions of dollars in payments from the Canada Emergency Wage Subsidy program, raising new questions about the policy intentions of the program and whether it meant to subsidize a sector that was already in the throes of consolidation.
A Globe and Mail analysis of company filings and publicly available data from the CEWS registry shows at least 20 publicly traded cannabis companies cumulatively collected more than $40-million in CEWS payments, while dozens of others received the subsidy but chose not to disclose the amount in their financial filings.